You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

VENTOLIN HFA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Ventolin Hfa patents expire, and when can generic versions of Ventolin Hfa launch?

Ventolin Hfa is a drug marketed by Glaxosmithkline and is included in one NDA.

The generic ingredient in VENTOLIN HFA is albuterol sulfate. There are thirty-eight drug master file entries for this compound. Forty-five suppliers are listed for this compound. Additional details are available on the albuterol sulfate profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Ventolin Hfa

A generic version of VENTOLIN HFA was approved as albuterol sulfate by SUN PHARM INDUSTRIES on December 5th, 1989.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VENTOLIN HFA?
  • What are the global sales for VENTOLIN HFA?
  • What is Average Wholesale Price for VENTOLIN HFA?
Drug patent expirations by year for VENTOLIN HFA
Drug Prices for VENTOLIN HFA

See drug prices for VENTOLIN HFA

Drug Sales Revenue Trends for VENTOLIN HFA

See drug sales revenues for VENTOLIN HFA

Recent Clinical Trials for VENTOLIN HFA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of AlbertaPhase 1
Canisius-Wilhelmina HospitalPhase 3
Hat Yai Medical Education CenterPhase 3

See all VENTOLIN HFA clinical trials

Pharmacology for VENTOLIN HFA

US Patents and Regulatory Information for VENTOLIN HFA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Glaxosmithkline VENTOLIN HFA albuterol sulfate AEROSOL, METERED;INHALATION 020983-001 Apr 19, 2001 BX RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for VENTOLIN HFA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Glaxosmithkline VENTOLIN HFA albuterol sulfate AEROSOL, METERED;INHALATION 020983-001 Apr 19, 2001 ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline VENTOLIN HFA albuterol sulfate AEROSOL, METERED;INHALATION 020983-001 Apr 19, 2001 ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline VENTOLIN HFA albuterol sulfate AEROSOL, METERED;INHALATION 020983-001 Apr 19, 2001 ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline VENTOLIN HFA albuterol sulfate AEROSOL, METERED;INHALATION 020983-001 Apr 19, 2001 ⤷  Sign Up ⤷  Sign Up
Glaxosmithkline VENTOLIN HFA albuterol sulfate AEROSOL, METERED;INHALATION 020983-001 Apr 19, 2001 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for VENTOLIN HFA

See the table below for patents covering VENTOLIN HFA around the world.

Country Patent Number Title Estimated Expiration
Bulgaria 62119 ⤷  Sign Up
European Patent Office 0988078 DISTRIBUTEUR A COMPTEUR DE DOSES (DISPENSER WITH DOSES' COUNTER) ⤷  Sign Up
Canada 2303685 MEDICAMENTS AEROSOLS AVEC PROPULSEUR FLUOROCARBONE (FLUOROCARBON AEROSOL MEDICAMENTS) ⤷  Sign Up
Canada 2455115 FORMULATION PHARMACEUTIQUE EN AEROSOL (PHARMACEUTICAL AEROSOL FORMULATION) ⤷  Sign Up
Australia 663904 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.